XCUR Stock Summary and Trading Ideas (Exicure | NASDAQ:XCUR)

Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Exicure trades on the NASDAQ stock market under the symbol XCUR.

As of March 4, 2025, XCUR stock price climbed to $14.28 with 222,758 million shares trading.

XCUR has a beta of 0.96, meaning it tends to be less sensitive to market movements. XCUR has a correlation of 0.00 to the broad based SPY ETF.

XCUR has a market cap of $43.40 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XCUR traded as high as $50.78 and as low as $1.44.

The top ETF exchange traded funds that XCUR belongs to (by Net Assets): VXF.

XCUR has outperformed the market in the last year with a price return of +285.9% while the SPY ETF gained +14.0%. However, in the short term, XCUR had mixed performance relative to the market. It has underperformed in the last 3 months, returning -33.6% vs -4.7% return in SPY. But in the last 2 weeks, XCUR shares have fared better than the market returning +68.0% compared to SPY -5.7%.

XCUR support price is $10.27 and resistance is $12.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XCUR shares will trade within this expected range on the day.